Entia Biosciences Stock Probability of Future Pink Sheet Price Finishing Under 1.0E-4
ERGO Stock | USD 0.0001 0.00 0.00% |
Entia |
Entia Biosciences Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Entia Biosciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Entia Biosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.Entia Biosciences generated a negative expected return over the last 90 days | |
Entia Biosciences has some characteristics of a very speculative penny stock | |
Entia Biosciences has a very high chance of going through financial distress in the upcoming years | |
The company has a current ratio of 0.11, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Entia Biosciences until it has trouble settling it off, either with new capital or with free cash flow. So, Entia Biosciences' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Entia Biosciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Entia to invest in growth at high rates of return. When we think about Entia Biosciences' use of debt, we should always consider it together with cash and equity. | |
Entia Biosciences reported the previous year's revenue of 265.47 K. Net Loss for the year was (1.4 M) with profit before overhead, payroll, taxes, and interest of 173.97 K. | |
Entia Biosciences currently holds about 76.05 K in cash with (715.1 K) of positive cash flow from operations. |
Entia Biosciences Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Entia Pink Sheet often depends not only on the future outlook of the current and potential Entia Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Entia Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding | 24.3 M | |
Cash And Short Term Investments | 76 K |
Entia Biosciences Technical Analysis
Entia Biosciences' future price can be derived by breaking down and analyzing its technical indicators over time. Entia Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Entia Biosciences. In general, you should focus on analyzing Entia Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
Entia Biosciences Predictive Forecast Models
Entia Biosciences' time-series forecasting models is one of many Entia Biosciences' pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Entia Biosciences' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about Entia Biosciences
Checking the ongoing alerts about Entia Biosciences for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Entia Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Entia Biosciences generated a negative expected return over the last 90 days | |
Entia Biosciences has some characteristics of a very speculative penny stock | |
Entia Biosciences has a very high chance of going through financial distress in the upcoming years | |
The company has a current ratio of 0.11, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Entia Biosciences until it has trouble settling it off, either with new capital or with free cash flow. So, Entia Biosciences' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Entia Biosciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Entia to invest in growth at high rates of return. When we think about Entia Biosciences' use of debt, we should always consider it together with cash and equity. | |
Entia Biosciences reported the previous year's revenue of 265.47 K. Net Loss for the year was (1.4 M) with profit before overhead, payroll, taxes, and interest of 173.97 K. | |
Entia Biosciences currently holds about 76.05 K in cash with (715.1 K) of positive cash flow from operations. |
Check out Entia Biosciences Backtesting, Entia Biosciences Valuation, Entia Biosciences Correlation, Entia Biosciences Hype Analysis, Entia Biosciences Volatility, Entia Biosciences History as well as Entia Biosciences Performance. Note that the Entia Biosciences information on this page should be used as a complementary analysis to other Entia Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Complementary Tools for Entia Pink Sheet analysis
When running Entia Biosciences' price analysis, check to measure Entia Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Entia Biosciences is operating at the current time. Most of Entia Biosciences' value examination focuses on studying past and present price action to predict the probability of Entia Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Entia Biosciences' price. Additionally, you may evaluate how the addition of Entia Biosciences to your portfolios can decrease your overall portfolio volatility.
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |